Abstract
Purpose: Human Papilloma Virus (HPV) infection leads to 26,000 new genitourinary and oropharyngeal cancers yearly. Routine recommendation for HPV adolescent immunization was made in 2007 for girls and 2011 for boys. Although this series is efficacious, HPV vaccination rates remain low nationwide, especially when compared to other vaccines of the adolescent platform. Our Pediatric and Adolescent Medicine clinic is evaluating our current HPV vaccination rates with the goal to reach series completion in at least 80% of our adolescents 13–17 years of age by the use of PDSA cycles.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
